| | 13.5y Risk Factors |
|---|
| HOMA-IR | Fat % | Sum of Skinfolds (mm) | Waist Circumference (cm) | Total:HDL Cholesterol | Triglycerides | SBP (mmHg) | Metabolic Syndrome Score§ |
|---|
| B (95% CI) |
|---|
| 6–10 year Physical Activity |
| Counts/day × 103 | −0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.01 | −0.01 |
| | (−0.02, 0.00) | (−0.01,0.01) | (− 0.01,0.01) | (− 0.01,0.01) | (− 0.01,0.01) | (− 0.01,0.01) | (− 0.02,0.00) | (− 0.01,0.02) |
| % time Moderate | − 0.05 | − 0.08 | 0.02 | 0.01 | 0.01 | 0.01 | − 0.02 | 0.05 |
| | (− 0.12, 0.02) | (− 0.31,0.46) | (−0.04,0.08) | (− 0.05,0.06) | (− 0.06,0.06) | (− 0.06,0.07) | (− 0.08,0.04) | (− 0.23,0.13) |
| % time Vigorous | − 0.08 | −0.11 | − 0.05 | − 0.05 | −0.12 | −0.10 | − 0.08) | − 0.40* |
| | (− 0.22, 0.05) | (− 0.87,-0.66) | (− 0.17,0.06) | (− 0.16,0.06) | (− 0.24,0.02) | (− 0.23,0.03) | (− 0.20,0.04) | (− 0.75,0.05) |
| 11–13 year Physical Activity |
| Counts/day × 103 | −0.01* | −0.01* | −0.01 | − 0.01 | 0.00 | 0.00 | 0.00 | −0.02 |
| | (−0.02,0.00) | (−0.01,−0.00) | (−0.02,0.00) | (− 0.02,0.00) | (− 0.01,0.01) | (− 0.01,0.01) | (−0.01,0.01) | (− 0.01,0.01) |
| % time Moderate | −0.04 | −0.44* | −0.04 | − 0.05* | −0.04 | −0.02 | 0.01 | −0.15* |
| | (−0.10,0.14) | (−0.77,−0.11) | (−0.09,0.01) | (− 0.10,0.00) | (− 0.09,0.02) | (− 0.08,0.03) | (−0.05,0.06) | (− 0.30,0.00) |
| % time Vigorous | −0.20* | −0.06* | −0.19* | − 0.17* | −0.15* | −0.13 | 0.20 | −0.51* |
| | (−0.36,−0.03) | (−0.11,−0.01) | (−0.33,−0.05) | (− 0.30,−0.03) | (− 0.31,−0.00) | (− 0.29,−0.02) | (0.00,0.35) | (− 0.94,-0.08) |
- †Models adjusted for Age at activity assessment, sex, pubertal stage at 13.5 years, standard of living, maternal GDM status. §Eisenmann et al. [26] *p < 0.05. HOMA-IR Homeostasis Model Assessment for insulin resistance SBP systolic blood pressure, B Beta, CI confidence interval
